Technical420 Site Search

TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of…

Activity within the Canadian cannabis industry has picked up over the last two weeks and we believe this is just beginning as the month of December has been highlighted by increased M&A activity, company funding agreements and new investment opportunities.One of the most highly anticipated initial public offerings (IPO) will…

With Canada on the verge of legalizing recreational cannabis, more capital has entered the industry.One the most significant developments in 2015 was Justin Trudeau’s and the Liberal Party’s success in the Canadian general election. The outcome was a huge victory for the cannabis industry and a catalyst for Canadian cannabis…

One of the sectors that have been hit the hardest during the last three months is the biotech sector and many investors are wondering if it is time to buy. Although recent weakness has made many biotech investments look attractive, we remain on the sidelines with many blue chip investments…

Recent volatility in the cannabis stock market has made it necessary for investors to have access to independent cannabis stock research. During the last week, Technical420 has made some great changes to its platform. We updated the website’s structure, we lowered our prices, and we are giving away our research…

Investors, it is time to set aside some cash! On Wednesday, Zynerba Pharmaceuticals, Inc. (ZYNE) will have its initial public offering (IPO) on the NASDAQ exchange. Zynerba will issue 3,000,000 shares and they will be offered in the $13.00-$15.00 range. The total offering amount is $51.75 million (total expenses are…

Yesterday, Zynerba Pharmaceuticals announced the terms of its upcoming initial public offering (IPO). The Pennsylvania-based company plans to raise $42 million by offering 3 million shares in the $13-$15 range. At the midpoint of the proposed range, it would have a fully diluted market value of $128 million. Shares are…

Investors and financial institutions have been patiently waiting for a cannabis-related company to commence trading on a national exchange like the Nasdaq or New York Stock Exchange. Currently, there are only two cannabis related biotech companies that trade on the Nasdaq. These are GW Pharmaceuticals (GWPH) and INSYS Therapeutics, Inc.…